首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

市場調查報告書

商品編碼

1800223

獸醫疫苗市場－2025年至2030年的預測

Veterinary Vaccines Market - Forecasts fom 2025 to 2030

出版日期: 2025年08月11日 | 出版商:

Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

獸用疫苗市場預計將從 2025 年的 93.54 億美元成長到 2030 年的 137.58 億美元，複合年成長率為 8.02%。

預計2025年至2030年間，獸用疫苗市場將經歷顯著成長，這主要得益於人畜共通感染疾病的增加、全球寵物擁有量的增加以及畜牧產品需求的不斷成長。減毒活病毒疫苗疫苗，包括減毒活疫苗、去活化疫苗、重組疫苗等，對於預防伴侶動物和農業動物的疾病感染，保護動物和人類的健康至關重要。這些疫苗主要透過腸外給藥，在動物保健產業中至關重要。儘管嚴格的監管可能是一個挑戰，但政府的舉措和向預防性醫療保健的轉變支撐著市場的發展。

市場促進因素

通用感染疾病的興起

人畜共通感染疾病的增加是獸用疫苗市場的主要驅動力。動物可以傳播細菌、病毒、寄生蟲和真菌等病原體，這些病原體會導致人類患上從輕微到致命的嚴重疾病。全球通用感染疾病的負擔凸顯了對有效獸用疫苗的需求，以預防動物間傳播。政府舉措，例如針對動物病毒爆發的項目，透過推廣疫苗接種作為主要預防措施，進一步推動了市場成長。這些措施在牲畜和寵物數量較多的地區尤其重要，因為這些地區的通用感染疾病的風險較高。

印度需求不斷成長

印度獸用疫苗市場正穩步成長，這得益於人口成長和飲食習慣變化推動的肉類和乳製品等畜產品需求的不斷成長。家禽和酪農對印度農業經濟的貢獻巨大，它們擴大採用疫苗來預防感染疾病並確保牲畜健康。農民對疫苗接種經濟效益的認知不斷提高，加上國家動物疾病控制計劃等政府項目，也推動了市場擴張。需求旺盛的疫苗包括針對鼠疫、掠食動物病（PPR）、布氏桿菌屬和口蹄疫（FMD）的疫苗，這反映出人們對牲畜健康的重視。

寵物擁有量增加

全球範圍內，寵物飼養人數呈上升趨勢，尤其是貓狗等伴侶動物。伴随这一趋势，宠物护理支出也随之增长，因为飼主更加重视预防性医疗保健，以保护宠物并降低通用感染疾病的风险。尤其是貓咪的日益普及，也促進了寵物護理市場的成長，因為飼主會尋求疫苗接種來確保寵物的健康和安全。

市場限制

獸用疫苗市場面臨嚴格的疫苗核准監管政策的挑戰，這可能會延遲疫苗的上市時間並增加上市成本。雖然這些法規確保了疫苗的安全性和有效性，但也限制了創新和可近性，尤其是對小型製造商而言。此外，先進疫苗的高成本可能會限制開發中國家等價格敏感市場的採用。透過簡化的監管流程和經濟高效的疫苗開發來應對這些挑戰，對於市場持續成長至關重要。

介紹
北美洲
- 按疫苗類型
- 按給藥方式
- 依動物類型
- 按國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 按疫苗類型
- 按給藥方式
- 依動物類型
- 按國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 按疫苗類型
- 按給藥方式
- 依動物類型
- 按國家
  - 德國
  - 法國
  - 英國
  - 西班牙
  - 其他
中東和非洲
- 按疫苗類型
- 按給藥方式
- 依動物類型
- 按國家
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 以色列
  - 其他
亞太地區
- 按疫苗類型
- 按給藥方式
- 依動物類型
- 按國家
  - 中國
  - 印度
  - 日本
  - 韓國
  - 印尼
  - 其他

第9章：競爭格局及分析

主要企業和策略分析
市場佔有率分析
合併、收購、協議和合作
競爭對手儀表板

第10章：公司簡介

Elanco
Zoetis Inc.
Ceva
Merck Animal Health
Phibro Animal Health Corporation
Virbac
Hester Bioscience Limited
Hipra
Boehringer Ingelheim International GmbH
AdvaCare Pharma

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
調查方法
簡稱

簡介目錄

Product Code: KSI061611783

The veterinary vaccines market is expected to grow from USD9.354 billion in 2025 to USD13.758 billion in 2030, at a CAGR of 8.02%.

The veterinary vaccines market is projected to experience significant growth from 2025 to 2030, driven by the rising prevalence of zoonotic diseases, increasing global pet adoption, and growing demand for livestock products. Veterinary vaccines, including live attenuated, inactivated, recombinant, and other types, are critical for preventing disease transmission in companion and agricultural animals, protecting both animal and human health. Administered primarily through parenteral methods, these vaccines are essential in the veterinary healthcare industry. The market is supported by government initiatives and a shift toward preventive healthcare, though stringent regulations may pose challenges.

Market Drivers

Rising Zoonotic Diseases

The increasing incidence of zoonotic diseases is a primary driver of the veterinary vaccines market. Animals can transmit pathogens such as bacteria, viruses, parasites, and fungi, which cause serious illnesses in humans, ranging from mild to fatal. The global burden of zoonotic diseases underscores the need for effective veterinary vaccines to prevent transmission from animals to humans. Government initiatives, such as programs targeting animal virus outbreaks, further boost market growth by promoting vaccination as a key preventive measure. These efforts are particularly critical in regions with high livestock and pet populations, where zoonotic risks are elevated.

Growing Demand in India

The Indian veterinary vaccines market is experiencing steady growth, driven by rising demand for livestock products like meat and dairy, fueled by population growth and changing dietary habits. The poultry and dairy sectors, major contributors to India's agricultural economy, are increasingly adopting vaccines to prevent infectious diseases and ensure healthy animal populations. Farmers' growing awareness of the economic benefits of vaccination, coupled with government programs like the National Animal Disease Control Programme, supports market expansion. High-demand vaccines include those for Peste des petits ruminants (PPR), Brucella, and Foot and Mouth Disease (FMD), reflecting the focus on livestock health.

Increasing Pet Adoption

Global pet adoption rates are rising, particularly for companion animals like dogs and cats, driving demand for veterinary vaccines. This trend is accompanied by increased pet care expenditures, as owners prioritize preventive healthcare to protect their pets and reduce zoonotic risks. The growing popularity of cats, in particular, is contributing to market growth, as pet owners seek vaccines to ensure animal health and safety.

Market Restraints

The veterinary vaccines market faces challenges due to stringent regulatory policies governing vaccine approvals, which can delay market entry and increase development costs. These regulations, while ensuring safety and efficacy, may limit innovation and accessibility, particularly for smaller manufacturers. Additionally, the high cost of advanced vaccines can restrict adoption in price-sensitive markets, such as developing regions, where affordability is a key concern. Addressing these challenges through streamlined regulatory processes and cost-effective vaccine development will be critical for sustained market growth.

Market Segmentation

By Product Type

The market includes live attenuated, inactivated, recombinant, and other vaccines. Parenteral administration dominates due to its effectiveness in delivering targeted immunity. Recombinant vaccines are gaining traction for their precision and safety in addressing specific pathogens.

By Animal Type

The market serves companion animals (e.g., dogs, cats) and agricultural animals (e.g., cattle, poultry). The companion animal segment is growing rapidly due to rising pet ownership, while the agricultural segment remains significant, driven by the need to maintain livestock health and productivity.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads due to high pet care spending and advanced veterinary infrastructure. Asia-Pacific, particularly India, is expected to grow steadily, driven by increasing livestock production and government support. Europe, South America, and the Middle East and Africa are also poised for growth, supported by rising awareness and improving veterinary services.

The veterinary vaccines market is set for robust growth from 2025 to 2030, driven by rising zoonotic disease risks, growing pet adoption, and increasing demand for livestock products, particularly in India. Despite challenges from stringent regulations and high costs, the market's outlook remains positive, with strong growth in North America and Asia-Pacific. Industry players must focus on innovative, cost-effective vaccines and regulatory compliance to capitalize on the growing demand for preventive animal healthcare solutions.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2020 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Vaccine Type

Live, Attenuated Vaccines
Inactivated/Killed Vaccines
Toxoid Vaccines
Subunit & Conjugate Vaccines
Others

By Mode of Administration

Oral
Parental
Others

By Animal

Companion Animals
Livestock Animals
Cattle
Poultry
Swine
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
UK
France
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
Thailand
Taiwan
Indonesia
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. VETERINARY VACCINE MARKET BY VACCINE TYPE

5.1. Introduction
5.2. Live Attenuated Vaccine
5.3. Inactive/Killed Vaccine
5.4. Toxoid Vaccine
5.5. Subunit & Conjugate Vaccine
5.6. Others

6. VETERINARY VACCINE MARKET BY MODE OF ADMINISTRATION

6.1. Introduction
6.2. Oral
6.3. Parental
6.4. Others

7. VETERINARY VACCINE MARKET BY ANIMAL TYPE

7.1. Introduction
7.2. Companion Animals
7.3. Livestock Animals
- 7.3.1. Cattle
- 7.3.2. Poultry
- 7.3.3. Swine
- 7.3.4. Others

8. VETERINARY VACCINE MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Vaccine Type
- 8.2.2. By Mode of Administration
- 8.2.3. By Animal Type
- 8.2.4. By Country
  - 8.2.4.1. USA
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Vaccine Type
- 8.3.2. By Mode of Administration
- 8.3.3. By Animal Type
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Vaccine Type
- 8.4.2. By Mode of Administration
- 8.4.3. By Animal Type
- 8.4.4. By Country
  - 8.4.4.1. Germany
  - 8.4.4.2. France
  - 8.4.4.3. United Kingdom
  - 8.4.4.4. Spain
  - 8.4.4.5. Others
8.5. Middle East and Africa
- 8.5.1. By Vaccine Type
- 8.5.2. By Mode of Administration
- 8.5.3. By Animal Type
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Israel
  - 8.5.4.4. Others
8.6. Asia Pacific
- 8.6.1. By Vaccine Type
- 8.6.2. By Mode of Administration
- 8.6.3. By Animal Type
- 8.6.4. By Country
  - 8.6.4.1. China
  - 8.6.4.2. India
  - 8.6.4.3. Japan
  - 8.6.4.4. South Korea
  - 8.6.4.5. Indonesia
  - 8.6.4.6. Others